Cancer Trials: US FDA Debuts Framework For Patient-Reported Tolerability Assessments

 
• By Sue Sutter
Construction framing
Oncology sponsors may want to use the FDA's new framework for determining the treatment-related symptoms to assess in clinical trials. • Source: Shutterstock

More from Clinical Trials

More from R&D